Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Ajinomoto Althea, Inc.
EIR
•Ajinomoto Althea, Inc.•March 22, 2019

Ajinomoto Althea, Inc. – FDA EIR, Mar 22, 2019

Record Details

An FDA pre-license inspection of Ajinomoto Althea, Inc., also known as Ajinomoto Bio-Pharma Services, was conducted from March 18 to March 22, 2019. This inspection supported Biologics License Applications for both a drug substance and a drug product, operating under the regulatory framework of FDA's Good Manufacturing Practice (GMP) for therapeutic drug products and active pharmaceutical ingredients, as outlined by the Food, Drug, and Cosmetic Act. The inspection covered quality, facilities, equipment, production, materials, and laboratory systems. While previous inspection deficiencies were verified as corrected, the current inspection resulted in a 3-item FDA Form 483, detailing new concerns. The main violations identified were inadequate deviation investigations, particularly regarding recurring incidents of broken vials where historical trends were not consistently assessed. The firm also demonstrated a lack of quality oversight, as crucial roles and responsibilities were not clearly defined in quality agreements with their drug substance and drug product sponsors. Additionally, the company failed to perform necessary clean hold time studies for a specific manufacturing system. In response to these observations, Ajinomoto Althea, Inc. management committed to submitting a formal reply within 15 business days, outlining their corrective actions.

Company
Ajinomoto Althea, Inc.
Inspection date
March 22, 2019
Product type
biologics
Office
Division of Pharmaceutical Quality Operations I
People
  • Thuy T. Nguyen ( Investigator, Consumer Safety Officer)
  • Ashley Queen (investigator)
  • Linda Thai (Team Biologics Staff)
View Company Profile

ID · fe37bed8-0f83-4083-9e69-8bb28b26b435

Violation Codes2
21 CFR 820.3021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Ajinomoto Althea, Inc.
  • 483 - 2025-05-09May 9, 2025
  • 483 - 2023-09-20September 20, 2023
  • 483 - 2023-02-09February 9, 2023
  • 483 - 2023-01-16January 16, 2023
  • 483 - 2021-05-25May 25, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ajinomoto Althea, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.